PURIDOSTIGMINE BROMIDE PRETREATMENT FOR NERVE AGENTS

File: 970107_oct96_decls2_0003.txt
Page: 0003
Total Pages: 3

Subject: PURIDOSTIGMINE BROMIDE PRETREATMENT FOR NERVE AGENTS            

Unit: COMUSMARCENT

Parent Organization: COMUSCINCCEN

Box  ID: BX600093

Folder Title: FOLDER NAVAL MESSAGE FILES AUG  OCT 90 ARMY REFERRAL                                            

Document Number:          5

Folder Seq  #:         34



                                                                          z25& ot--
        I tqOIED IA(E                 U N C L A S S I F I Elt             TOD = 234 1341

           D. FLIGHT SURGEONS AND AVIATION MEDICAI. SAFETY OFFICERS
        SHOULD BEGIN BRIEFING ACREWS ASAP CONCERNING USE AND POTENTIAL SIDE
        EFFECTS OF PYRIDOSTIGMINE. EMPHASIS TO BE PLACED ON POTENTIAL
        PAGE 05 RLJLSBUA8141 IJNCL.AS
        VISUAL IMPAIRMEtl-f, PARTICULARLY UT NIGHT, AS WELL AS DECREASE IN
        HEAT TOLERANCE.
           E. PRETESTING AVIATION PERSONNEL IS NOT REQUIRED TO DETERMINE
        ADVERSE EFFECTS.
        5'. STORAGE REQUIREMENTS. NERVE AGENT PYRIDOSTIGMINE PRETREATMENT
        (NAPP) TABLET SET SHOULD BE STORED REFREGERATED IN TEMPERATURE
        RANGES OF 35 TO 46 DEGREES FARETIHEIT (2 TO 8 DEGREES CENT16RADE).
        IF NAPP is NOT REFRIGERATED, THE MA)(IMIJM USABLE SHELF LIFE IS SIX
        (6) @IOIJ-fHS, AF WHICH TIME IT WILL HAVE LOST ITS POTENCY AND SHOULD
        NOT BE LISED.
        10. RESPONSIBILITIES. LOWEST LEVEL CHAIN OF COMMAND WILL DECIDE
        If) BEGIN, CONTINUE OR DISCONTINUE THE NAPP PRETREATMENT MEDICATION



        PAGE 06 RbFRSGG6313 UNCI.AL@
        BASED ON THREAT. INTE:-Llt3ENCE OFFICERS AND MED DEPT REPS ACT AS
        ADIVSORS TO THE COMMAhjl)ER/CO IN MAKING THE DECISION IF A CHEVIICAL
        THREAT EXISTS. AFTER THREI. (3) BAYS OF SERVICE PERSONNEI. SELF
        MEDICATION, COMMANDER(:O ATIO STAFF SHOULD IIEEVALUATE COMI)AI
        SITUAflOti TO DETERMINE IF MEDICATPON StiOLIL.D BE CONTINUED OR
        DISCONTINUED. ORDERS TJ crit4rlNtJr OR DISCONTINUE PRETREATMENT CAN
        AND SHOUL.0 BE MADE AT Aj4.1 FIME DEPENDING ON THE SITUATION. IF
        PI,IETREATMENT 13 CGNI'INUEI) FOR SEVEN (7) DAYS, AN ADDITIONAL NAPP
        PA(IE 06 RULSBLJA8141 UNCLA@
        MUST BE ISSUED AND ADDITIONAL PACKS ORDERED. ADMLNISTER;NG THE
        MEDICATION BEYOND TWI-'
        A THCIROUGFF EVALUATION OF SITUATION. THE MAGNITUDE OF THREAT MAY
DVERSE SIDE EFFECTS AND INDICATE CONTINUING
        PRETREATMENI'.
        11. P(J(' RESPONSE CELL IS AV            CML                  AND CDR
        PATRICK A. TRUMAN, MSC, USN, AV             OR COLL I
        E;T
        06313
















        IMMEDI.tkTE                   U N C L A S S I F I E D

Document 3 f:/Week-44/BX600093/FOLDER NAVAL MESSAGE FILES AUG OCT 90 ARMY REFERRAL/puridostigmine bromide pretreatment for nerve ag:01029709371915
Control Fields 17
File Room = oct96_declassified
File Cabinet = Week-44
Box ID = BX600093
Unit = COMUSMARCENT
Parent Organization = COMUSCINCCEN
Folder Title = FOLDER NAVAL MESSAGE FILES AUG OCT 90 ARMY REFERRAL
Folder Seq # = 34
Subject = PURIDOSTIGMINE BROMIDE PRETREATMENT FOR NERVE AG
Document Seq # = 5
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 02-JAN-1997